Cargando…

Treatment of negative dysphotopsia with supplementary implantation of a sulcus-fixated intraocular lens

PURPOSE: Our aim was to evaluate the resolution of negative dysphotopsia after supplementary implantation of a sulcus-fixated intraocular lens (IOL). METHODS: This was a retrospective case series. Patients with severe negative dysphotopsia were treated with supplementary implantation of the Rayner S...

Descripción completa

Detalles Bibliográficos
Autores principales: Makhotkina, Natalia Y., Berendschot, Tos T. J. M., Beckers, Henny J. M., Nuijts, Rudy M. M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445254/
https://www.ncbi.nlm.nih.gov/pubmed/25947640
http://dx.doi.org/10.1007/s00417-015-3029-8
Descripción
Sumario:PURPOSE: Our aim was to evaluate the resolution of negative dysphotopsia after supplementary implantation of a sulcus-fixated intraocular lens (IOL). METHODS: This was a retrospective case series. Patients with severe negative dysphotopsia were treated with supplementary implantation of the Rayner Sulcoflex Aspheric (653 L) IOL. Primary outcome measurements were subjectively reported complaints of dysphotopsia, best corrected distance visual acuity (CDVA), iris-IOL distance, anterior chamber depth (ACD) and volume (ACV), angle opening distance and trabecular-iris space area at 500 and 750 μm. RESULTS: A Rayner Sulcoflex IOL was implanted in seven patients (nine eyes) with negative dysphotopsias. Symptoms resolved completely in six eyes, partially in one eye and remained unchanged in two eyes. We did not find any significant changes in CDVA. Angle opening distance, ACD, ACV and iris-IOL distance reduced significantly after Sulcoflex IOL implantation. CONCLUSIONS: Supplementary implantation of a Sulcoflex IOL can successfully treat negative dysphotopsia. The decrease in anterior segment dimensions in combination with the displacement of light rays by the rounded edges of a Sulcoflex IOL may contribute to the resolution of symptoms.